Statement Of Financial Position [Abstract]

Zealand Pharma - Filing #1350008

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
47,047,000 DKK
50,528,000 DKK
Right-of-use assets
102,805,000 DKK
114,960,000 DKK
Intangible assets other than goodwill
12,255,000 DKK
- DKK
Deferred tax assets
925,000 DKK
2,017,000 DKK
Cash and cash equivalents
449,311,000 DKK
1,069,234,000 DKK
1,129,103,000 DKK
Assets
1,979,993,000 DKK
1,539,806,000 DKK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
58,751,000 DKK
51,702,000 DKK
Retained earnings
4,894,841,000 DKK
4,171,640,000 DKK
Share premium
6,406,225,000 DKK
4,921,232,000 DKK
Equity
6,406,225,000 DKK
58,751,000 DKK
22,704,000 DKK
4,894,841,000 DKK
1,592,839,000 DKK
815,911,000 DKK
4,921,232,000 DKK
4,171,640,000 DKK
51,702,000 DKK
14,617,000 DKK
927,803,000 DKK
3,021,979,000 DKK
3,891,993,000 DKK
14,155,000 DKK
43,634,000 DKK
Liabilities [abstract]
Liabilities
387,154,000 DKK
723,895,000 DKK
Equity and liabilities
1,979,993,000 DKK
1,539,806,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.